HSV DRUGS

Pharmaceutical compositions comprising glucocorticoid receptor II antagonists, their enantiomers and isomers, antisense, inhibitory RNA, and peptide mimetic compounds targeting EIF3/mov34 and/or GR II useful to treat Herpes Simplex Virus (Types 1 and 2) infections are disclosed. Methods of treating...

Full description

Saved in:
Bibliographic Details
Main Author KIM, JONG, JOSEPH
Format Patent
LanguageEnglish
French
Published 31.05.2007
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Pharmaceutical compositions comprising glucocorticoid receptor II antagonists, their enantiomers and isomers, antisense, inhibitory RNA, and peptide mimetic compounds targeting EIF3/mov34 and/or GR II useful to treat Herpes Simplex Virus (Types 1 and 2) infections are disclosed. Methods of treating individuals infected with Herpes Simplex Virus (Types 1 and 2) are disclosed. L'invention concerne des compositions pharmaceutiques contenant des antagonistes du récepteur glucocorticoïde de type II, leurs énantiomères et isomères, composés antisens, ARN inhibiteur, et composés mimétiques peptidiques, ciblés sur EIF3/mov34 et/ou GR I, servant à traiter les infections par les virus Herpès Simplex (types I et II). L'invention concerne également des méthodes permettant de traiter des individus présentant une infection par un virus Herpes Simplex (types 1 and 2).
AbstractList Pharmaceutical compositions comprising glucocorticoid receptor II antagonists, their enantiomers and isomers, antisense, inhibitory RNA, and peptide mimetic compounds targeting EIF3/mov34 and/or GR II useful to treat Herpes Simplex Virus (Types 1 and 2) infections are disclosed. Methods of treating individuals infected with Herpes Simplex Virus (Types 1 and 2) are disclosed. L'invention concerne des compositions pharmaceutiques contenant des antagonistes du récepteur glucocorticoïde de type II, leurs énantiomères et isomères, composés antisens, ARN inhibiteur, et composés mimétiques peptidiques, ciblés sur EIF3/mov34 et/ou GR I, servant à traiter les infections par les virus Herpès Simplex (types I et II). L'invention concerne également des méthodes permettant de traiter des individus présentant une infection par un virus Herpes Simplex (types 1 and 2).
Author KIM, JONG, JOSEPH
Author_xml – fullname: KIM, JONG, JOSEPH
BookMark eNrjYmDJy89L5WTg9AgOU3AJCnUP5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgYGZobGxoaWFo7GxsSpAgBj_R46
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate MEDICAMENTS ANTI-VHS
ExternalDocumentID WO2006133198A3
GroupedDBID EVB
ID FETCH-epo_espacenet_WO2006133198A33
IEDL.DBID EVB
IngestDate Fri Jul 19 11:39:30 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_WO2006133198A33
Notes Application Number: WO2006US21931
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070531&DB=EPODOC&CC=WO&NR=2006133198A3
ParticipantIDs epo_espacenet_WO2006133198A3
PublicationCentury 2000
PublicationDate 20070531
PublicationDateYYYYMMDD 2007-05-31
PublicationDate_xml – month: 05
  year: 2007
  text: 20070531
  day: 31
PublicationDecade 2000
PublicationYear 2007
RelatedCompanies KIM, JONG, JOSEPH
VGX PHARMACEUTICALS, INC
RelatedCompanies_xml – name: VGX PHARMACEUTICALS, INC
– name: KIM, JONG, JOSEPH
Score 2.6779711
Snippet Pharmaceutical compositions comprising glucocorticoid receptor II antagonists, their enantiomers and isomers, antisense, inhibitory RNA, and peptide mimetic...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title HSV DRUGS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070531&DB=EPODOC&locale=&CC=WO&NR=2006133198A3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSU6zNLA0t0zSTU20TNE1SQT2WZMsUo11U4FVT6JBGrAFYgHa4OzrZ-YRauIVYRrBxJAD2wsDPie0HHw4IjBHJQPzewm4vC5ADGK5gNdWFusnZQKF8u3dQmxd1GC9Y3NQmlJzcbJ1DfB38XdWc3YG9tvU_ILAPWdgdwzYxXY0ZmZgBTakzUH5wTXMCbQvpQC5UnETZGALAJqXVyLEwJSaJ8zA6Qy7e02YgcMXOuUNZEJzX7EIA6dHcJiCS1Coe7Aog7Kba4izhy7QzHi4F-LD_ZEdYCzGwALs3KdKMCgkmpmkGCcZmSWlGaSZmCZaJJqbmwIbPaYpRkmJoMaLJIMMPpOk8EtLM3BBxiJBs90yDCwlRaWpssBKtCRJDux3AEmAcjc
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSU6zNLA0t0zSTU20TNE1SQT2WZMsUo11U4FVT6JBGrAFYgHa4OzrZ-YRauIVYRrBxJAD2wsDPie0HHw4IjBHJQPzewm4vC5ADGK5gNdWFusnZQKF8u3dQmxd1GC9Y3NQmlJzcbJ1DfB38XdWc3YG9tvU_ILAPWdgdwzYxXY0ZmZgBTayzUH5wTXMCbQvpQC5UnETZGALAJqXVyLEwJSaJ8zA6Qy7e02YgcMXOuUNZEJzX7EIA6dHcJiCS1Coe7Aog7Kba4izhy7QzHi4F-LD_ZEdYCzGwALs3KdKMCgkmpmkGCcZmSWlGaSZmCZaJJqbmwIbPaYpRkmJoMaLJIMMPpOk8EvLA10W4usT7-Pp5y3NwAUZlwTNfMswsJQUlabKAivUkiQ5cDgAAM6xdSo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=HSV+DRUGS&rft.inventor=KIM%2C+JONG%2C+JOSEPH&rft.date=2007-05-31&rft.externalDBID=A3&rft.externalDocID=WO2006133198A3